A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence.

Trial Profile

A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 15 Oct 2012

At a glance

  • Drugs Aripiprazole; Perphenazine
  • Indications Cocaine abuse; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Oct 2012 Lead trial centre amended as reported by ClinicalTrials.gov.
    • 15 Oct 2012 Planned End Date changed from 1 Oct 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 17 Jan 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top